HQY Stock Chart & Stats
$1670.41
$0.00(0.00%)
At close: 4:00 PM EDT
$1670.41
$0.00(0.00%)
Day’s Range― - ―
52-Week Range$1,670.41 - $1,870.49
Previous CloseN/A
Volume0.00
Average Volume (3M)0.00
Market Cap
$130.46B
Enterprise Value$9.17K
Total Cash (Recent Filing)$256.00M
Total Debt (Recent Filing)$971.02M
Price to Earnings (P/E)33.1
Beta0.04
Next Earnings
Dec 08, 2026EPS Estimate
19.45Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)2.80
Shares Outstanding82,715,294
10 Day Avg. Volume0
30 Day Avg. Volume0
Financial Highlights & Ratios
PEG Ratio0.27
Price to Book (P/B)3.50
Price to Sales (P/S)5.62
P/FCF Ratio16.21
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
$2,009.17Price Target Upside20.28% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering10
EPS Forecast (FY)79.89
Revenue Forecast (FY)$23.96B
Bulls Say, Bears Say
Bulls Say
HSA Scale And Asset GrowthA large and growing HSA base strengthens HealthEquity’s platform economics, supports recurring administration and custodial revenue, and increases opportunities to expand payment, investing, and digital services over time.
Sustained Profitability And Margin ExpansionRecord gross profit and expanding EBITDA margins indicate operating leverage in the platform. Continued automation and scale can help protect profitability as accounts and transactions grow, supporting durable earnings conversion.
Strong Cash Generation And Operating EfficiencyRobust operating and free cash flow gives HealthEquity flexibility to fund technology, growth initiatives, debt reduction, repurchases, and potential acquisitions while reducing reliance on external capital.
Bears Say
Competitive Pressure On Service PricingPricing pressure can reduce revenue per account and force HealthEquity to share efficiency gains with clients. Sustained competition could limit service-fee growth and weaken the ability to preserve expanding margins.
Slower Growth Outside Core HSAsReliance on HSA growth makes the company more exposed to one dominant product and limits diversification. Slower adoption of FSAs, HRAs, and other benefits could constrain account density and cross-sell potential.
Debt And Custodial-yield ConstraintsMaterial reported debt requires continued cash allocation discipline, particularly alongside repurchases and possible M&A. In addition, long-term hedges reduce custodial-yield volatility but can cap upside if rates rise.
Healthequity News
HQY FAQ
What was Healthequity’s price range in the past 12 months?
Healthequity lowest stock price was $1670.41 and its highest was $1870.49 in the past 12 months.
What is Healthequity’s market cap?
Healthequity’s market cap is $130.46B.
When is Healthequity’s upcoming earnings report date?
Healthequity’s upcoming earnings report date is Dec 08, 2026 which is in 89 days.
How were Healthequity’s earnings last quarter?
Healthequity released its earnings results on Aug 27, 2026. The company reported $20.971 earnings per share for the quarter, beating the consensus estimate of $20.176 by $0.795.
Is Healthequity overvalued?
According to Wall Street analysts Healthequity’s price is currently Undervalued.
Does Healthequity pay dividends?
Healthequity does not currently pay dividends.
What is Healthequity’s EPS estimate?
Healthequity’s EPS estimate is 19.45.
How many shares outstanding does Healthequity have?
Healthequity has 82,715,294 shares outstanding.
What happened to Healthequity’s price movement after its last earnings report?
Healthequity reported an EPS of $20.971 in its last earnings report, beating expectations of $20.176. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Healthequity?
Currently, no hedge funds are holding shares in MX:HQY
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Healthequity Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$2,009.17 (20.28% Upside)
$2,009.17 (20.28% Upside)
Blogger Sentiment
Bullish
MX:HQY Sentiment 75%
Sector Average 60%
Sector Average 60%
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Positive
20 days / 200 days
Momentum
-0.35%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
-4.25%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
Healthequity
Headquartered in Draper, Utah, and established in 2002, HealthEquity, Inc. furnishes technology-powered service platforms to both individual consumers and employers across the United States. The company provides cloud-based solutions designed to assist individuals in overseeing their healthcare expenditures and savings. These platforms enable users to make informed decisions about their health finances, pay medical bills, compare treatment options and costs, access personalized benefits and clinical data, earn incentives for wellness, and grow their savings through various investment avenues, including specific investment choices. In addition to these personal financial management tools, HealthEquity administers a range of health-related accounts, such as Health Savings Accounts (HSAs), Flexible Spending Accounts (FSAs), and Health Reimbursement Arrangements (HRAs). Its offerings also encompass a mutual fund investment platform, an automated online advisory service known as Advisor, COBRA continuation services, and the management of pre-tax commuter benefits programs. HealthEquity markets its services through a dedicated direct sales team, collaborates with benefits brokers and advisors, and leverages a comprehensive network comprising health plans, benefits administrators, consultants, and retirement plan record-keepers.
HQY Earnings Call
Q2 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call conveyed strong operational and financial momentum: accelerated revenue growth, record gross profit and adjusted EBITDA margin expansion, raised fiscal 2027 guidance, robust HSA account and asset growth, meaningful digital and AI-driven efficiency gains, and healthy cash generation enabling share repurchases. Key risks and near-term constraints include marketplace revenue still being immaterial, competitive price pressure on service fees, hedging that limits yield upside, modest total account growth outside HSAs, and a small current share of investing HSA members. Overall, the positive execution, raised guidance, and margin durability materially outweigh the noted challenges.View all MX:HQY earnings summariesHQY Revenue Breakdown
49.92% Service revenue
32.85% Custodial revenue
17.23% Interchange revenue
HQY Stock 12 Month Forecast
Average Price Target
$2,009.17
▲(20.28% Upside)
Technical Analysis
Teladoc
―
GoodRx Holdings
―
Waystar Holding Corp.
―
Hinge Health, Inc. Class A
―
Omada Health, Inc.
―